SymBio Pharmaceuticals Limited
TSE:4582.T
233 (JPY) • At close November 5, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | SymBio Pharmaceuticals Limited |
Symbool | 4582.T |
Munteenheid | JPY |
Prijs | 234 |
Beurswaarde | 10,723,198,824 |
Dividendpercentage | 0% |
52-weken bereik | 146 - 475 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Fuminori Yoshida |
Website | https://www.symbiopharma.com |
An error occurred while fetching data.
Over SymBio Pharmaceuticals Limited
SymBio Pharmaceuticals Limited engages in the research and development, manufacturing, and marketing of pharmaceutical drugs in the areas of oncology and hematology in Japan. It is involved in the development of Treakisym SyB L-0501, an anti-cancer agent, which is marketed for the treatment of non-Hodgkin's lymphoma, multiple myeloma, and chronic
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (JPY)
Cijfers zijn in miljoenen (JPY)